メトホルミンの妊産前症候群における役割: 体系的なレビュー
Manoharan Anuja1, Manoharan Arthy1, Nivedita Jha1
1Department of Obstetrics and Gynecology, Jawaharlal Institute of Postgraduate Medical Education and Research (JIPMER), Puducherry, India.
Journal of obstetrics and gynaecology of India
|August 25, 2025
まとめ
メトホルミンは妊娠中の妊婦の妊娠前出血症と子宮内生殖抑制を著しく減少させる. 妊娠中の高血圧疾患の予防と治療における効果を確認するには,さらなるランダム化試験が必要である.
科学分野:
- 産婦人科
- 薬理学について
- 妊婦と胎児の医療
背景:
- 妊産婦と新生児の死亡の主な原因です
- メトフォーミンは,心血管機能を改善し,妊娠中の体重増加を減少させることで,妊娠前出血症を予防する可能性を示しています.
研究 の 目的:
- 妊娠前症におけるメトホルミンの役割と結果を体系的に検討する.
- メトホルミンサプリメントによる妊産婦および子周期のアウトカム評価
主な方法:
- PubMed,Web of Science,Psyc INFO,CINAHLの出版物の体系的なレビューについて
- "メトホルミン"と"妊娠前出血症" または"高血圧"と"妊娠期"で検索しました.
主要な成果:
- 4つの研究では,メトホルミンは重度の妊娠前出血症の発生率を有意に減少させました (12. 1% vs 20. 7%).
- メトフォーミンは妊娠前出血症と子宮内成長制限の割合を低下させた (P=0. 04,P=0. 035).
- メトフォーミン治療後に母親のsEngとsFLT-1のレベルが低下した.
結論:
- メトホルミンは,慢性高血圧の妊婦の重複性妊娠前出血症を効果的に軽減しました.
- メトホルミンは,妊娠に関連した高血圧障害の予防に他の薬よりも優れている可能性があります.
- 研究の限界のために,さらによく設計されたランダム化試験は不可欠です.
関連する概念動画
Oral Hypoglycemic Agents: Biguanides and Glitazones
291
Biguanides, particularly metformin (Glucophage), are insulin sensitizers that enhance glucose uptake, thereby reducing insulin resistance. Unlike sulfonylureas, metformin doesn't prompt insulin secretion, which helps to curb hypoglycemia risk. Metformin is beneficial in treating conditions like polycystic ovary syndrome due to its insulin-resistance reduction capability. The drug's primary action involves curtailing hepatic gluconeogenesis, a significant contributor to high blood...
291
Pathophysiology of Diabetes
1.2K
Diabetes mellitus is a chronic metabolic disorder characterized by hyperglycemia. The four categories of diabetes are type 1 diabetes, type 2 diabetes, other specific types of diabetes, and gestational diabetes.
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
1.2K
Diabetes Mellitus: Type 2 and Gestational
2.9K
Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
2.9K
Dipeptidyl Peptidase 4 Inhibitors
256
Dipeptidyl peptidase 4 (DPP-4) is a serine protease widely distributed in the body. It's involved in the inactivation of GLP-1 and GIP hormones, which are crucial for insulin regulation. DPP-4 inhibitors, such as sitagliptin (Januvia), saxagliptin (Onglyza), linagliptin (Tradjenta), alogliptin (Nesina), and vildagliptin (Galvus), help increase the proportion of active GLP-1, enhancing insulin secretion. These inhibitors work by competitively binding to DPP-4. This binding causes a...
256
Hormonal Regulation
33.7K
The renin-aldosterone system is an endocrine system which guides the renal absorption of water and electrolytes, thus managing blood pressure and osmoregulation. Activation of the system begins in the kidneys with a small cluster of cells adjacent to the afferent and efferent blood vessels of the renal corpuscle. As the nephrons are filtering blood, juxtaglomerular cells monitor blood pressure. If they detect a decrease in pressure, they release the hormone renin into the bloodstream.
33.7K
Adrenergic Antagonists: ɑ and β-Receptor Blockers
598
Third-generation β-blockers, such as labetalol and carvedilol, represent a significant advancement in managing cardiovascular conditions. Unlike conventional β-blockers, which can induce peripheral vasoconstriction, third-generation drugs block α1 adrenoceptors. This promotes vasodilation through several mechanisms, such as increased nitric oxide production, inhibition of calcium ion entry, opening of potassium ion channels, and antioxidant action. Labetalol, for instance, is...
598


